Trial Outcomes & Findings for Optimizing a Mobile Mindfulness Intervention for ICU Survivors (NCT NCT04038567)

NCT ID: NCT04038567

Last Updated: 2024-08-15

Results Overview

Absolute values, not change scores. Depression symptoms. Scores range from 0 (better) to 27 (worse)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

247 participants

Primary outcome timeframe

1 month post-randomization

Results posted on

2024-08-15

Participant Flow

Note that this is a factorial experimental trial in which 3 factors were examined, each at 2 levels (i.e., a 2\^3 design). In this trial the 3 factors and 2 levels are as follows: 1. Introduction to intervention (app introduction vs. therapist introduction) 2. Dose (standard vs. high) 3. Response to depression symptoms that increase during the intervention period (app response vs. therapist response)

Participant milestones

Participant milestones
Measure
App Introduction to Intervention, High Dose, and Therapist Response
Introduction to intervention via the mobile app itself. High dose of meditation time (twice a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, High Dose, and Therapist Response
Introduction to intervention via a call from the study therapist. High dose of meditation time (twice a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, Standard Dose, and Therapist Response
Introduction to intervention via the mobile app itself. Standard dose of meditation time (once a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, Standard Dose, and Therapist Response
Introduction to intervention via a call from the study therapist. Standard dose of meditation time (once a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, High Dose, and App Response
Introduction to intervention via the mobile app itself. High dose of meditation time (twice a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, High Dose, and App Response
Introduction to intervention via a call from the study therapist. High dose of meditation time (twice a day). Mobile app response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, Standard Dose, and App Response
Introduction to intervention via the mobile app itself. Standard dose of meditation time (once a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, Standard Dose, and App Response
Introduction to intervention via a call from the study therapist. Standard dose of meditation time (once a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Overall Study
STARTED
30
31
31
32
32
31
30
30
Overall Study
COMPLETED
21
23
23
25
19
24
22
25
Overall Study
NOT COMPLETED
9
8
8
7
13
7
8
5

Reasons for withdrawal

Reasons for withdrawal
Measure
App Introduction to Intervention, High Dose, and Therapist Response
Introduction to intervention via the mobile app itself. High dose of meditation time (twice a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, High Dose, and Therapist Response
Introduction to intervention via a call from the study therapist. High dose of meditation time (twice a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, Standard Dose, and Therapist Response
Introduction to intervention via the mobile app itself. Standard dose of meditation time (once a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, Standard Dose, and Therapist Response
Introduction to intervention via a call from the study therapist. Standard dose of meditation time (once a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, High Dose, and App Response
Introduction to intervention via the mobile app itself. High dose of meditation time (twice a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, High Dose, and App Response
Introduction to intervention via a call from the study therapist. High dose of meditation time (twice a day). Mobile app response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, Standard Dose, and App Response
Introduction to intervention via the mobile app itself. Standard dose of meditation time (once a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, Standard Dose, and App Response
Introduction to intervention via a call from the study therapist. Standard dose of meditation time (once a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Overall Study
Lost to Follow-up
6
4
5
4
6
4
4
1
Overall Study
Withdrawal by Subject
2
1
1
1
4
1
1
1
Overall Study
missed survey window
1
2
0
0
1
1
2
2
Overall Study
technical issues
0
0
0
0
0
0
1
0
Overall Study
Medical issues (i.e., illness)
0
1
2
1
1
1
0
0
Overall Study
Death
0
0
0
1
1
0
0
1

Baseline Characteristics

Optimizing a Mobile Mindfulness Intervention for ICU Survivors

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
App Introduction to Intervention, High Dose, and Therapist Response
n=30 Participants
Introduction to intervention via the mobile app itself. High dose of meditation time (twice a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, High Dose, and Therapist Response
n=31 Participants
Introduction to intervention via a call from the study therapist. High dose of meditation time (twice a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, Standard Dose, and Therapist Response
n=31 Participants
Introduction to intervention via the mobile app itself. Standard dose of meditation time (once a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, Standard Dose, and Therapist Response
n=32 Participants
Introduction to intervention via a call from the study therapist. Standard dose of meditation time (once a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, High Dose, and App Response
n=32 Participants
Introduction to intervention via the mobile app itself. High dose of meditation time (twice a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, High Dose, and App Response
n=31 Participants
Introduction to intervention via a call from the study therapist. High dose of meditation time (twice a day). Mobile app response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, Standard Dose, and App Response
n=30 Participants
Introduction to intervention via the mobile app itself. Standard dose of meditation time (once a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, Standard Dose, and App Response
n=30 Participants
Introduction to intervention via a call from the study therapist. Standard dose of meditation time (once a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Total
n=247 Participants
Total of all reporting groups
Age, Continuous
55.3 years
STANDARD_DEVIATION 15.0 • n=5 Participants
51.6 years
STANDARD_DEVIATION 14.6 • n=7 Participants
48.2 years
STANDARD_DEVIATION 15.7 • n=5 Participants
48.8 years
STANDARD_DEVIATION 14.8 • n=4 Participants
47.4 years
STANDARD_DEVIATION 16.4 • n=21 Participants
49.4 years
STANDARD_DEVIATION 17.1 • n=8 Participants
51.3 years
STANDARD_DEVIATION 14.4 • n=8 Participants
49.4 years
STANDARD_DEVIATION 15.2 • n=24 Participants
50.22 years
STANDARD_DEVIATION 15.38 • n=42 Participants
Sex: Female, Male
Female
12 Participants
n=5 Participants
11 Participants
n=7 Participants
13 Participants
n=5 Participants
15 Participants
n=4 Participants
10 Participants
n=21 Participants
16 Participants
n=8 Participants
16 Participants
n=8 Participants
11 Participants
n=24 Participants
104 Participants
n=42 Participants
Sex: Female, Male
Male
18 Participants
n=5 Participants
20 Participants
n=7 Participants
18 Participants
n=5 Participants
17 Participants
n=4 Participants
22 Participants
n=21 Participants
15 Participants
n=8 Participants
14 Participants
n=8 Participants
19 Participants
n=24 Participants
143 Participants
n=42 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
3 Participants
n=4 Participants
1 Participants
n=21 Participants
4 Participants
n=8 Participants
5 Participants
n=8 Participants
4 Participants
n=24 Participants
24 Participants
n=42 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
26 Participants
n=5 Participants
29 Participants
n=7 Participants
29 Participants
n=5 Participants
27 Participants
n=4 Participants
30 Participants
n=21 Participants
26 Participants
n=8 Participants
24 Participants
n=8 Participants
26 Participants
n=24 Participants
217 Participants
n=42 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
2 Participants
n=4 Participants
1 Participants
n=21 Participants
1 Participants
n=8 Participants
1 Participants
n=8 Participants
0 Participants
n=24 Participants
6 Participants
n=42 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
1 Participants
n=21 Participants
0 Participants
n=8 Participants
0 Participants
n=8 Participants
3 Participants
n=24 Participants
5 Participants
n=42 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
2 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
0 Participants
n=8 Participants
0 Participants
n=24 Participants
3 Participants
n=42 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
1 Participants
n=21 Participants
0 Participants
n=8 Participants
0 Participants
n=8 Participants
1 Participants
n=24 Participants
3 Participants
n=42 Participants
Race (NIH/OMB)
Black or African American
5 Participants
n=5 Participants
4 Participants
n=7 Participants
4 Participants
n=5 Participants
3 Participants
n=4 Participants
8 Participants
n=21 Participants
6 Participants
n=8 Participants
4 Participants
n=8 Participants
1 Participants
n=24 Participants
35 Participants
n=42 Participants
Race (NIH/OMB)
White
21 Participants
n=5 Participants
24 Participants
n=7 Participants
24 Participants
n=5 Participants
25 Participants
n=4 Participants
17 Participants
n=21 Participants
24 Participants
n=8 Participants
21 Participants
n=8 Participants
23 Participants
n=24 Participants
179 Participants
n=42 Participants
Race (NIH/OMB)
More than one race
3 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
2 Participants
n=4 Participants
1 Participants
n=21 Participants
0 Participants
n=8 Participants
3 Participants
n=8 Participants
1 Participants
n=24 Participants
12 Participants
n=42 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
4 Participants
n=21 Participants
1 Participants
n=8 Participants
2 Participants
n=8 Participants
1 Participants
n=24 Participants
10 Participants
n=42 Participants
Region of Enrollment
United States
30 participants
n=5 Participants
31 participants
n=7 Participants
31 participants
n=5 Participants
32 participants
n=4 Participants
32 participants
n=21 Participants
31 participants
n=8 Participants
30 participants
n=8 Participants
30 participants
n=24 Participants
247 participants
n=42 Participants

PRIMARY outcome

Timeframe: 1 month post-randomization

Population: Participants who had data collected at both time points.

Absolute values, not change scores. Depression symptoms. Scores range from 0 (better) to 27 (worse)

Outcome measures

Outcome measures
Measure
Standard Dose
n=97 Participants
Standard dose of meditation time (once a day).
High Dose
n=94 Participants
High dose of meditation time (twice a day).
App Response
n=92 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=99 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=91 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=100 Participants
Introduction to intervention via a call from the study therapist.
Patient Health Questionnaire-9 Item Scale (PHQ-9)
7.0 units on a scale
Standard Deviation 5.2
5.6 units on a scale
Standard Deviation 4.2
6.2 units on a scale
Standard Deviation 5.3
6.4 units on a scale
Standard Deviation 4.3
6.2 units on a scale
Standard Deviation 4.7
6.4 units on a scale
Standard Deviation 4.8

SECONDARY outcome

Timeframe: Between baseline 1 month post-randomization

Population: Participants who had data collected at both time points.

Absolute values, not change scores. Anxiety symptoms. Scores range from 0 (better) to 21 (worse)

Outcome measures

Outcome measures
Measure
Standard Dose
n=95 Participants
Standard dose of meditation time (once a day).
High Dose
n=87 Participants
High dose of meditation time (twice a day).
App Response
n=88 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=94 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=87 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=95 Participants
Introduction to intervention via a call from the study therapist.
Generalized Anxiety Disorder 7-item Scale (GAD-7)
6.2 units on a scale
Standard Deviation 5.3
4.2 units on a scale
Standard Deviation 4.3
5.1 units on a scale
Standard Deviation 4.7
5.3 units on a scale
Standard Deviation 5.1
5.5 units on a scale
Standard Deviation 5.4
4.9 units on a scale
Standard Deviation 4.5

SECONDARY outcome

Timeframe: Between baseline 3 months post-randomization

Population: Participants who had data collected at both time points.

Absolute values, not change scores. Depression symptoms. Scores range from 0 (better) to 27 (worse)

Outcome measures

Outcome measures
Measure
Standard Dose
n=95 Participants
Standard dose of meditation time (once a day).
High Dose
n=87 Participants
High dose of meditation time (twice a day).
App Response
n=88 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=94 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=87 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=95 Participants
Introduction to intervention via a call from the study therapist.
Patient Health Questionnaire-9 Item Scale (PHQ-9)
8.12 units on a scale
Standard Deviation 6.23
6.10 units on a scale
Standard Deviation 4.65
6.73 units on a scale
Standard Deviation 5.69
7.55 units on a scale
Standard Deviation 5.53
7.28 units on a scale
Standard Deviation 5.76
7.04 units on a scale
Standard Deviation 5.50

SECONDARY outcome

Timeframe: Between baseline 3 months post-randomization

Population: Participants who had data collected at both time points.

Absolute values, not change scores. Anxiety symptoms. Scores range from 0 (better) to 21 (worse)

Outcome measures

Outcome measures
Measure
Standard Dose
n=95 Participants
Standard dose of meditation time (once a day).
High Dose
n=87 Participants
High dose of meditation time (twice a day).
App Response
n=88 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=94 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=87 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=95 Participants
Introduction to intervention via a call from the study therapist.
Generalized Anxiety Disorder 7-item Scale (GAD-7)
6.83 units on a scale
Standard Deviation 5.74
4.38 units on a scale
Standard Deviation 4.12
6.25 units on a scale
Standard Deviation 5.45
5.11 units on a scale
Standard Deviation 4.86
5.62 units on a scale
Standard Deviation 5.07
5.69 units on a scale
Standard Deviation 5.28

SECONDARY outcome

Timeframe: Between baseline 3 months post-randomization

Population: Participants who had data collected at both time points.

Absolute values, not change scores. PTSD symptoms. Scores can range from 10 (best) to 70 (worst).

Outcome measures

Outcome measures
Measure
Standard Dose
n=95 Participants
Standard dose of meditation time (once a day).
High Dose
n=87 Participants
High dose of meditation time (twice a day).
App Response
n=88 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=94 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=87 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=95 Participants
Introduction to intervention via a call from the study therapist.
Post-Traumatic Stress Symptom Inventory (PTSS)
31.75 units on a scale
Standard Deviation 24.05
25.67 units on a scale
Standard Deviation 13.05
29.75 units on a scale
Standard Deviation 23.95
27.99 units on a scale
Standard Deviation 14.89
29.94 units on a scale
Standard Deviation 23.88
27.83 units on a scale
Standard Deviation 15.10

SECONDARY outcome

Timeframe: 1 month post-randomization

Quantified by number with activity (or not) in app during final week (4) of intervention

Outcome measures

Outcome measures
Measure
Standard Dose
n=124 Participants
Standard dose of meditation time (once a day).
High Dose
n=120 Participants
High dose of meditation time (twice a day).
App Response
n=123 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=124 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=125 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=122 Participants
Introduction to intervention via a call from the study therapist.
Intervention Adherence: Activity in App During Final Week of Intervention
112 Participants
104 Participants
105 Participants
111 Participants
105 Participants
108 Participants

SECONDARY outcome

Timeframe: 1 month post-randomization

Quantified by mean (SD) number of intervention content (audio, video, text) views

Outcome measures

Outcome measures
Measure
Standard Dose
n=124 Participants
Standard dose of meditation time (once a day).
High Dose
n=120 Participants
High dose of meditation time (twice a day).
App Response
n=123 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=124 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=125 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=122 Participants
Introduction to intervention via a call from the study therapist.
Intervention Adherence: Number of Views of Content
34.88 mobile app content views
Standard Deviation 35.81
39.38 mobile app content views
Standard Deviation 31.38
40.53 mobile app content views
Standard Deviation 38.31
33.70 mobile app content views
Standard Deviation 28.14
34.24 mobile app content views
Standard Deviation 31.37
40.03 mobile app content views
Standard Deviation 35.82

SECONDARY outcome

Timeframe: 3 months post-randomization

Population: Data not collected.

A measure of acceptability. Scores can range from 8 (worst) to 32 (best)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3 months post-randomization

Population: Data not collected.

A measure of intervention usability. Each of 10 items is scored from 1 to 5. For each of the odd numbered questions, subtract 1 from the score. For each of the even numbered questions, subtract their value from 5. Take these new values and add up the total score. Then multiply this by 2.5.Scores can range from 0 (worst) to 100 (best)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Between baseline and 1 month post-randomization

Population: Participants who had data collected at both time points.

This is the absolute value, not change score. A measure of mindfulness qualities. Scores can range from 5 (worst) to 30 (best).

Outcome measures

Outcome measures
Measure
Standard Dose
n=97 Participants
Standard dose of meditation time (once a day).
High Dose
n=94 Participants
High dose of meditation time (twice a day).
App Response
n=92 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=99 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=91 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=100 Participants
Introduction to intervention via a call from the study therapist.
Mindful Attention Awareness Scale (MAAS)
22.86 units on a scale
Standard Deviation 5.06
24.04 units on a scale
Standard Deviation 5.71
23.31 units on a scale
Standard Deviation 5.67
23.59 units on a scale
Standard Deviation 5.18
23.41 units on a scale
Standard Deviation 5.22
23.49 units on a scale
Standard Deviation 5.61

SECONDARY outcome

Timeframe: Between baseline 3 months post-randomization

Population: Participants who had data collected at both time points.

These are absolute values, not change scores. A measure of mindfulness qualities. Scores can range from 5 (worst) to 30 (best).

Outcome measures

Outcome measures
Measure
Standard Dose
n=95 Participants
Standard dose of meditation time (once a day).
High Dose
n=87 Participants
High dose of meditation time (twice a day).
App Response
n=88 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=94 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=87 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=95 Participants
Introduction to intervention via a call from the study therapist.
Mindful Attention Awareness Scale (MAAS)
22.43 units on a scale
Standard Deviation 5.79
23.08 units on a scale
Standard Deviation 5.94
22.57 units on a scale
Standard Deviation 6.23
22.90 units on a scale
Standard Deviation 5.51
22.43 units on a scale
Standard Deviation 5.51
23.03 units on a scale
Standard Deviation 6.17

SECONDARY outcome

Timeframe: Between baseline and 1 month post-randomization

Population: Participants who had data collected at both time points.

These are absolute values, not change scores. An adapted version of the PHQ-15; a measure of physical symptoms. Scores can range from 10 (best) to 20 (worst).

Outcome measures

Outcome measures
Measure
Standard Dose
n=97 Participants
Standard dose of meditation time (once a day).
High Dose
n=94 Participants
High dose of meditation time (twice a day).
App Response
n=92 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=99 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=91 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=100 Participants
Introduction to intervention via a call from the study therapist.
Patient Health Questionnaire 10-item Scale (PHQ-10)
6.66 units on a scale
Standard Deviation 3.44
6.02 units on a scale
Standard Deviation 3.16
6.31 units on a scale
Standard Deviation 3.32
6.37 units on a scale
Standard Deviation 3.32
6.50 units on a scale
Standard Deviation 3.16
6.19 units on a scale
Standard Deviation 3.45

SECONDARY outcome

Timeframe: Between baseline 3 months post-randomization

Population: Participants who had data collected at both time points.

This is an absolute value, not a change score. An adapted version of the PHQ-15; a measure of physical symptoms. Scores can range from 10 (best) to 20 (worst).

Outcome measures

Outcome measures
Measure
Standard Dose
n=87 Participants
Standard dose of meditation time (once a day).
High Dose
n=95 Participants
High dose of meditation time (twice a day).
App Response
n=88 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=94 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=95 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=87 Participants
Introduction to intervention via a call from the study therapist.
Patient Health Questionnaire 10-item Scale (PHQ-10)
6.15 units on a scale
Standard Deviation 3.86
5.64 units on a scale
Standard Deviation 3.28
5.85 units on a scale
Standard Deviation 3.58
5.96 units on a scale
Standard Deviation 3.62
6.21 units on a scale
Standard Deviation 3.44
5.63 units on a scale
Standard Deviation 3.72

SECONDARY outcome

Timeframe: Between baseline and 1 month post-randomization

Population: Participants who had data collected at both time points.

This is an absolute, not change, value. the EuroQOL is a measure of quality of life. Scores can range from 0 (worst) to 100 (best)

Outcome measures

Outcome measures
Measure
Standard Dose
n=97 Participants
Standard dose of meditation time (once a day).
High Dose
n=94 Participants
High dose of meditation time (twice a day).
App Response
n=92 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=99 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=91 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=100 Participants
Introduction to intervention via a call from the study therapist.
EuroQOL Scale
58.87 units on a scale
Standard Deviation 21.98
66.56 units on a scale
Standard Deviation 21.64
63.91 units on a scale
Standard Deviation 21.43
61.43 units on a scale
Standard Deviation 22.75
61.56 units on a scale
Standard Deviation 23.07
63.60 units on a scale
Standard Deviation 21.25

SECONDARY outcome

Timeframe: Between baseline 3 months post-randomization

Population: Participants who had data collected at both time points.

A measure of quality of life. Scores can range from 0 (worst) to 100 (best)

Outcome measures

Outcome measures
Measure
Standard Dose
n=97 Participants
Standard dose of meditation time (once a day).
High Dose
n=94 Participants
High dose of meditation time (twice a day).
App Response
n=92 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=99 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=91 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=100 Participants
Introduction to intervention via a call from the study therapist.
Change in EuroQOL Scale
61.68 units on a scale
Standard Deviation 24.15
66.21 units on a scale
Standard Deviation 22.48
65.02 units on a scale
Standard Deviation 24.87
62.74 units on a scale
Standard Deviation 22.03
62.07 units on a scale
Standard Deviation 22.23
65.47 units on a scale
Standard Deviation 24.44

SECONDARY outcome

Timeframe: Between baseline and 1 month post-randomization; THIS WAS NOT RECORDED

Population: Data were not collected

A visual analog scale appended to the PHQ-9 which allows participants to report how distressing they perceive the depression symptoms to be that they reported in the PHQ-9. Scores range from 0 (best) to 100 (worst)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: At 1 month post-randomization

A visual analog scale appended to the PHQ-9 which allows participants to report how distressing they perceive the depression symptoms to be that they reported in the PHQ-9. Scores range from 0 (best) to 100 (worst)

Outcome measures

Outcome measures
Measure
Standard Dose
n=97 Participants
Standard dose of meditation time (once a day).
High Dose
n=94 Participants
High dose of meditation time (twice a day).
App Response
n=92 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=99 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=91 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=100 Participants
Introduction to intervention via a call from the study therapist.
Distress Associated With Depression Symptom Frequency
44.26 units on a scale
Standard Deviation 28.96
34.02 units on a scale
Standard Deviation 25.14
41.34 units on a scale
Standard Deviation 28.36
37.25 units on a scale
Standard Deviation 26.78
41.22 units on a scale
Standard Deviation 28.53
37.40 units on a scale
Standard Deviation 26.65

SECONDARY outcome

Timeframe: At 1 month post-randomization

A visual analog scale appended to the GAD-7 which allows participants to report how distressing they perceive the depression symptoms to be that they reported in the GAD-7. Scores range from 0 (best) to 100 (worst)

Outcome measures

Outcome measures
Measure
Standard Dose
n=124 Participants
Standard dose of meditation time (once a day).
High Dose
n=123 Participants
High dose of meditation time (twice a day).
App Response
n=123 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=124 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=125 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=122 Participants
Introduction to intervention via a call from the study therapist.
Distress Associated With Anxiety Symptom Frequency
50.11 units on a scale
Standard Deviation 26.07
44.67 units on a scale
Standard Deviation 25.38
48.57 units on a scale
Standard Deviation 24.47
46.24 units on a scale
Standard Deviation 27.15
45.31 units on a scale
Standard Deviation 26.50
49.54 units on a scale
Standard Deviation 25.04

SECONDARY outcome

Timeframe: Between baseline 3 months post-randomization

Population: Data were not collected

A visual analog scale appended to the GAD-7 which allows participants to report how distressing they perceive the depression symptoms to be that they reported in the GAD-7. Scores range from 0 (best) to 100 (worst)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: At 1 month post-randomization

A visual analog scale appended to the PTSS which allows participants to report how distressing they perceive the depression symptoms to be that they reported in the PTSS. Scores range from 0 (best) to 100 (worst)

Outcome measures

Outcome measures
Measure
Standard Dose
n=124 Participants
Standard dose of meditation time (once a day).
High Dose
n=123 Participants
High dose of meditation time (twice a day).
App Response
n=123 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=124 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=125 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=122 Participants
Introduction to intervention via a call from the study therapist.
Distress Associated With PTSD Symptom Frequency
49.56 units on a scale
Standard Deviation 28.59
42.02 units on a scale
Standard Deviation 30.54
47.69 units on a scale
Standard Deviation 28.63
43.94 units on a scale
Standard Deviation 30.84
44.60 units on a scale
Standard Deviation 30.52
47.04 units on a scale
Standard Deviation 29.04

SECONDARY outcome

Timeframe: At 3 months post-randomization

Population: Data were not collected

Absolute values, not change scores. A visual analog scale appended to the PTSS which allows participants to report how distressing they perceive the depression symptoms to be that they reported in the PTSS. Scores range from 0 (best) to 100 (worst)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Between baseline and 1 month post-randomization

Population: Participants who had data collected at both time points.

Absolute values, not change scores. Post-traumatic stress disorder symptoms. Scores can range from 10 (best) to 70 (worst).

Outcome measures

Outcome measures
Measure
Standard Dose
n=97 Participants
Standard dose of meditation time (once a day).
High Dose
n=94 Participants
High dose of meditation time (twice a day).
App Response
n=92 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=99 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=91 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=100 Participants
Introduction to intervention via a call from the study therapist.
Post-Traumatic Stress Symptom Inventory (PTSS)
31.53 units on a scale
Standard Deviation 28.04
23.65 units on a scale
Standard Deviation 11.04
29.53 units on a scale
Standard Deviation 27.81
25.77 units on a scale
Standard Deviation 13.36
28.91 units on a scale
Standard Deviation 28.14
26.38 units on a scale
Standard Deviation 13.08

SECONDARY outcome

Timeframe: 1 month post-randomization

A measure of acceptability. Scores can range from 8 (worst) to 32 (best)

Outcome measures

Outcome measures
Measure
Standard Dose
n=97 Participants
Standard dose of meditation time (once a day).
High Dose
n=94 Participants
High dose of meditation time (twice a day).
App Response
n=92 Participants
Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Response
n=99 Participants
Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention
n=91 Participants
Introduction to intervention via the mobile app itself.
Therapist Introduction to Intervention
n=100 Participants
Introduction to intervention via a call from the study therapist.
Client Satisfaction Questionnaire (CSQ)
24.86 units on a scale
Standard Deviation 5.11
25.71 units on a scale
Standard Deviation 4.10
25.81 units on a scale
Standard Deviation 4.58
24.79 units on a scale
Standard Deviation 4.67
25.27 units on a scale
Standard Deviation 4.46
25.31 units on a scale
Standard Deviation 4.82

SECONDARY outcome

Timeframe: 1 month post-randomization

Population: Data not collected.

A measure of intervention usability. Each of 10 items is scored from 1 to 5. For each of the odd numbered questions, subtract 1 from the score. For each of the even numbered questions, subtract their value from 5. Take these new values and add up the total score. Then multiply this by 2.5.Scores can range from 0 (worst) to 100 (best)

Outcome measures

Outcome data not reported

Adverse Events

App Introduction to Intervention, High Dose, and Therapist Response

Serious events: 6 serious events
Other events: 0 other events
Deaths: 0 deaths

Therapist Introduction to Intervention, High Dose, and Therapist Response

Serious events: 4 serious events
Other events: 1 other events
Deaths: 0 deaths

App Introduction to Intervention, Standard Dose, and Therapist Response

Serious events: 1 serious events
Other events: 1 other events
Deaths: 0 deaths

Therapist Introduction to Intervention, Standard Dose, and Therapist Response

Serious events: 2 serious events
Other events: 1 other events
Deaths: 1 deaths

App Introduction to Intervention, High Dose, and App Response

Serious events: 3 serious events
Other events: 1 other events
Deaths: 1 deaths

Therapist Introduction to Intervention, High Dose, and App Response

Serious events: 5 serious events
Other events: 1 other events
Deaths: 0 deaths

App Introduction to Intervention, Standard Dose, and App Response

Serious events: 2 serious events
Other events: 1 other events
Deaths: 0 deaths

Therapist Introduction to Intervention, Standard Dose, and App Response

Serious events: 2 serious events
Other events: 2 other events
Deaths: 1 deaths

Serious adverse events

Serious adverse events
Measure
App Introduction to Intervention, High Dose, and Therapist Response
n=30 participants at risk
Introduction to intervention via the mobile app itself. High dose of meditation time (twice a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, High Dose, and Therapist Response
n=31 participants at risk
Introduction to intervention via a call from the study therapist. High dose of meditation time (twice a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, Standard Dose, and Therapist Response
n=31 participants at risk
Introduction to intervention via the mobile app itself. Standard dose of meditation time (once a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, Standard Dose, and Therapist Response
n=32 participants at risk
Introduction to intervention via a call from the study therapist. Standard dose of meditation time (once a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, High Dose, and App Response
n=32 participants at risk
Introduction to intervention via the mobile app itself. High dose of meditation time (twice a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, High Dose, and App Response
n=31 participants at risk
Introduction to intervention via a call from the study therapist. High dose of meditation time (twice a day). Mobile app response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, Standard Dose, and App Response
n=30 participants at risk
Introduction to intervention via the mobile app itself. Standard dose of meditation time (once a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, Standard Dose, and App Response
n=30 participants at risk
Introduction to intervention via a call from the study therapist. Standard dose of meditation time (once a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Respiratory, thoracic and mediastinal disorders
Hospitalization
20.0%
6/30 • Number of events 6 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
12.9%
4/31 • Number of events 4 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
3.2%
1/31 • Number of events 8 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
6.2%
2/32 • Number of events 2 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
9.4%
3/32 • Number of events 3 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
16.1%
5/31 • Number of events 5 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
6.7%
2/30 • Number of events 2 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
6.7%
2/30 • Number of events 2 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')

Other adverse events

Other adverse events
Measure
App Introduction to Intervention, High Dose, and Therapist Response
n=30 participants at risk
Introduction to intervention via the mobile app itself. High dose of meditation time (twice a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, High Dose, and Therapist Response
n=31 participants at risk
Introduction to intervention via a call from the study therapist. High dose of meditation time (twice a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, Standard Dose, and Therapist Response
n=31 participants at risk
Introduction to intervention via the mobile app itself. Standard dose of meditation time (once a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, Standard Dose, and Therapist Response
n=32 participants at risk
Introduction to intervention via a call from the study therapist. Standard dose of meditation time (once a day). Therapist call in response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, High Dose, and App Response
n=32 participants at risk
Introduction to intervention via the mobile app itself. High dose of meditation time (twice a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, High Dose, and App Response
n=31 participants at risk
Introduction to intervention via a call from the study therapist. High dose of meditation time (twice a day). Mobile app response to elevated psychological distress symptoms during intervention period.
App Introduction to Intervention, Standard Dose, and App Response
n=30 participants at risk
Introduction to intervention via the mobile app itself. Standard dose of meditation time (once a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Therapist Introduction to Intervention, Standard Dose, and App Response
n=30 participants at risk
Introduction to intervention via a call from the study therapist. Standard dose of meditation time (once a day). Mobile app response to elevated psychological distress symptoms during intervention period.
Psychiatric disorders
Suicidal ideation (per PHQ-9 item 9)
0.00%
0/30 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
3.2%
1/31 • Number of events 1 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
3.2%
1/31 • Number of events 1 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
3.1%
1/32 • Number of events 1 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
3.1%
1/32 • Number of events 1 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
3.2%
1/31 • Number of events 1 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
3.3%
1/30 • Number of events 1 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')
6.7%
2/30 • Number of events 2 • 3 months
Adverse events: 1. death 2. hospitalization for any reason 3. Suicidal ideation as indicated by a response on the PHQ-9 item 9 as any response other than 0 ('never')

Additional Information

Christopher Cox

Duke University

Phone: 919-681-7232

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place